NB

Neurocrine Biosciences

Organization

Heard in 3 episodes across 3 shows since Aug 2026

Neurocrine Biosciences is a biopharmaceutical company that develops and commercializes medicines for neurological, endocrine and psychiatric disorders.

Learn moreEmail alerts

Episodes

3
across 3 shows

First heard

Aug 2026

Expert statements

3
3 positive

Episodes per month

Public PodLume episodes featuring it, over the last year.

Show the data
MonthEpisodes
Dec 20250
Jan 20260
Feb 20260
Mar 20260
Apr 20260
May 20260
Jun 20260
Jul 20260
Aug 20261
Sep 20260
Oct 20260
Nov 20262

Email alert

Email me when Neurocrine Biosciences comes up on a podcast

One email a week at most, with the new episodes that mention Neurocrine Biosciences. Free, no account needed, unsubscribe in one click.

What experts have said about Neurocrine Biosciences

3 statements · 3 positive

  1. Brian SkorneyPositiveNov 6, 2026· Biotech Hangout

    Any cash flow from Neurocrine’s Vykat deal could benefit its stock.

    “are they going to generate any sort of cashflow from the deal would, would maybe be a positive for the stock.”

    Listen at 35:17

    Open the episode · Episode 202 - November 6, 2026
  2. Jim CramerPositiveAug 17, 2026· Mad Money w/ Jim Cramer

    Cramer approves Neurocrine because it is profitable.

    “Because it's profitable, I'm going to say fine.”

    Listen at 35:49

    Open the episode · Mad Money w/ Jim Cramer 8/17/26
  3. Jim CramerPositiveAug 17, 2026· Mad Money w/ Jim Cramer

    Cramer evaluates Neurocrine Biosciences as performing well.

    “But I will say NeuroCream does a good job.”

    Listen at 36:01

    Open the episode · Mad Money w/ Jim Cramer 8/17/26
Filter the statements →

Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.

Episodes

3 episodes featuring Neurocrine Biosciences, newest first